AstraZeneca PLC is 118.1x more valuable than IDEAYA Biosciences, Inc. by market capitalization ($286.27 B vs $2.42 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IDYA | AZN |
|---|---|---|
| Market cap | $2.42 B | $286.27 B |
| US-listed rank | #1966 | #45 |
| Revenue (latest FY) | $218.71M | - |
| Net income (latest FY) | -$113.70M | - |
| Net margin | -52.0% | - |
| SEC filings | 477 | 1,004 |
AstraZeneca PLC is 118.1x more valuable than IDEAYA Biosciences, Inc. by market capitalization ($286.27 B vs $2.42 B).
Full pages: IDEAYA Biosciences, Inc. and AstraZeneca PLC, or browse the full rankings.